Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 185.73 Million USD | 17.29% |
| 2022 | 158.35 Million USD | -18.62% |
| 2021 | 194.59 Million USD | 15.3% |
| 2020 | 168.76 Million USD | 5.57% |
| 2019 | 159.86 Million USD | -2.6% |
| 2018 | 164.13 Million USD | 20.16% |
| 2017 | 136.59 Million USD | 2.78% |
| 2016 | 132.89 Million USD | 32.62% |
| 2015 | 100.21 Million USD | -4.46% |
| 2014 | 104.88 Million USD | 2.91% |
| 2013 | 101.92 Million USD | -1.87% |
| 2012 | 103.87 Million USD | -36.14% |
| 2011 | 162.65 Million USD | -4.48% |
| 2010 | 170.27 Million USD | -8.24% |
| 2009 | 185.56 Million USD | -2.86% |
| 2008 | 191.02 Million USD | 11.5% |
| 2007 | 171.33 Million USD | 8.85% |
| 2006 | 157.4 Million USD | 26.71% |
| 2005 | 124.22 Million USD | 13.16% |
| 2004 | 109.78 Million USD | 12.24% |
| 2003 | 97.8 Million USD | 26.62% |
| 2002 | 77.24 Million USD | 27.51% |
| 2001 | 60.58 Million USD | 19.38% |
| 2000 | 50.74 Million USD | 58.59% |
| 1999 | 32 Million USD | 31.69% |
| 1998 | 24.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 180.24 Million USD | -2.96% |
| 2024 Q3 | 177.41 Million USD | -2.95% |
| 2024 Q2 | 182.8 Million USD | 1.42% |
| 2023 Q3 | 188.9 Million USD | 13.68% |
| 2023 Q4 | 185.73 Million USD | -1.68% |
| 2023 FY | 185.73 Million USD | 17.29% |
| 2023 Q1 | 169.75 Million USD | 7.2% |
| 2023 Q2 | 166.16 Million USD | -2.12% |
| 2022 Q1 | 184.86 Million USD | -5.0% |
| 2022 Q2 | 184.18 Million USD | -0.37% |
| 2022 Q3 | 175.65 Million USD | -4.63% |
| 2022 Q4 | 158.35 Million USD | -9.85% |
| 2022 FY | 158.35 Million USD | -18.62% |
| 2021 Q1 | 163.55 Million USD | -3.09% |
| 2021 FY | 194.59 Million USD | 15.3% |
| 2021 Q2 | 177.09 Million USD | 8.28% |
| 2021 Q4 | 194.59 Million USD | 9.82% |
| 2021 Q3 | 177.19 Million USD | 0.06% |
| 2020 Q3 | 166.49 Million USD | 7.04% |
| 2020 Q2 | 155.54 Million USD | 0.32% |
| 2020 Q1 | 155.05 Million USD | -3.01% |
| 2020 FY | 168.76 Million USD | 5.57% |
| 2020 Q4 | 168.76 Million USD | 1.36% |
| 2019 Q3 | 150.34 Million USD | -0.42% |
| 2019 FY | 159.86 Million USD | -2.6% |
| 2019 Q2 | 150.98 Million USD | 0.21% |
| 2019 Q1 | 150.66 Million USD | -8.21% |
| 2019 Q4 | 159.86 Million USD | 6.33% |
| 2018 Q2 | 163.31 Million USD | 21.38% |
| 2018 Q4 | 164.13 Million USD | 2.59% |
| 2018 FY | 164.13 Million USD | 20.16% |
| 2018 Q1 | 134.55 Million USD | -1.49% |
| 2018 Q3 | 159.98 Million USD | -2.04% |
| 2017 Q3 | 131.89 Million USD | 0.45% |
| 2017 FY | 136.59 Million USD | 2.78% |
| 2017 Q4 | 136.59 Million USD | 3.57% |
| 2017 Q2 | 131.29 Million USD | 2.07% |
| 2017 Q1 | 128.62 Million USD | -3.21% |
| 2016 Q3 | 126.91 Million USD | 3.62% |
| 2016 FY | 132.89 Million USD | 32.62% |
| 2016 Q2 | 122.48 Million USD | 9.15% |
| 2016 Q1 | 112.21 Million USD | 11.98% |
| 2016 Q4 | 132.89 Million USD | 4.71% |
| 2015 Q1 | 87.12 Million USD | -16.94% |
| 2015 Q2 | 90.69 Million USD | 4.09% |
| 2015 Q4 | 100.21 Million USD | 4.4% |
| 2015 Q3 | 95.98 Million USD | 5.84% |
| 2015 FY | 100.21 Million USD | -4.46% |
| 2014 Q4 | 104.88 Million USD | 4.14% |
| 2014 Q1 | 95.05 Million USD | -6.74% |
| 2014 Q2 | 95.68 Million USD | 0.66% |
| 2014 Q3 | 100.71 Million USD | 5.26% |
| 2014 FY | 104.88 Million USD | 2.91% |
| 2013 Q4 | 101.92 Million USD | -1.93% |
| 2013 Q3 | 103.92 Million USD | -3.41% |
| 2013 Q1 | 107.81 Million USD | 3.8% |
| 2013 Q2 | 107.59 Million USD | -0.21% |
| 2013 FY | 101.92 Million USD | -1.87% |
| 2012 Q1 | 151.98 Million USD | -6.56% |
| 2012 FY | 103.87 Million USD | -36.14% |
| 2012 Q3 | 157.67 Million USD | 2.12% |
| 2012 Q2 | 154.4 Million USD | 1.59% |
| 2012 Q4 | 103.87 Million USD | -34.12% |
| 2011 FY | 162.65 Million USD | -4.48% |
| 2011 Q1 | 172.33 Million USD | 1.21% |
| 2011 Q2 | 171.52 Million USD | -0.47% |
| 2011 Q3 | 173.44 Million USD | 1.12% |
| 2011 Q4 | 162.65 Million USD | -6.22% |
| 2010 Q4 | 170.27 Million USD | -10.78% |
| 2010 Q3 | 190.86 Million USD | 0.18% |
| 2010 Q2 | 190.51 Million USD | 0.0% |
| 2010 Q1 | 190.5 Million USD | 2.67% |
| 2010 FY | 170.27 Million USD | -8.24% |
| 2009 Q3 | 181.68 Million USD | -0.19% |
| 2009 FY | 185.56 Million USD | -2.86% |
| 2009 Q1 | 180.4 Million USD | -5.56% |
| 2009 Q2 | 182.04 Million USD | 0.91% |
| 2009 Q4 | 185.56 Million USD | 2.13% |
| 2008 Q2 | 185.03 Million USD | 6.48% |
| 2008 FY | 191.02 Million USD | 11.5% |
| 2008 Q4 | 191.02 Million USD | -2.16% |
| 2008 Q3 | 195.25 Million USD | 5.52% |
| 2008 Q1 | 173.77 Million USD | 1.43% |
| 2007 Q2 | 138.18 Million USD | -8.93% |
| 2007 Q4 | 171.33 Million USD | 3.93% |
| 2007 Q1 | 151.73 Million USD | -3.6% |
| 2007 Q3 | 164.85 Million USD | 19.3% |
| 2007 FY | 171.33 Million USD | 8.85% |
| 2006 Q3 | 144.4 Million USD | 6.25% |
| 2006 Q4 | 157.4 Million USD | 9.0% |
| 2006 Q2 | 135.9 Million USD | 4.04% |
| 2006 Q1 | 130.62 Million USD | 5.15% |
| 2006 FY | 157.4 Million USD | 26.71% |
| 2005 Q2 | 109.48 Million USD | -1.09% |
| 2005 Q1 | 110.69 Million USD | 0.84% |
| 2005 FY | 124.22 Million USD | 13.16% |
| 2005 Q4 | 124.22 Million USD | 5.45% |
| 2005 Q3 | 117.8 Million USD | 7.6% |
| 2004 Q3 | 94.56 Million USD | -7.02% |
| 2004 FY | 109.78 Million USD | 12.24% |
| 2004 Q4 | 109.78 Million USD | 16.09% |
| 2004 Q1 | 99.18 Million USD | 1.41% |
| 2004 Q2 | 101.7 Million USD | 2.54% |
| 2003 FY | 97.8 Million USD | 26.62% |
| 2003 Q3 | 94.52 Million USD | 11.72% |
| 2003 Q2 | 84.61 Million USD | 7.27% |
| 2003 Q1 | 78.87 Million USD | 2.11% |
| 2003 Q4 | 97.8 Million USD | 3.47% |
| 2002 Q2 | 64.8 Million USD | 5.28% |
| 2002 Q1 | 61.55 Million USD | 1.6% |
| 2002 Q4 | 77.24 Million USD | 9.58% |
| 2002 Q3 | 70.49 Million USD | 8.78% |
| 2002 FY | 77.24 Million USD | 27.51% |
| 2001 Q3 | 56.85 Million USD | 4.11% |
| 2001 Q4 | 60.58 Million USD | 6.56% |
| 2001 FY | 60.58 Million USD | 19.38% |
| 2001 Q2 | 54.6 Million USD | 4.92% |
| 2001 Q1 | 52.04 Million USD | 2.56% |
| 2000 Q4 | 50.74 Million USD | 44.0% |
| 2000 Q2 | 33.25 Million USD | 2.97% |
| 2000 FY | 50.74 Million USD | 58.59% |
| 2000 Q1 | 32.3 Million USD | 0.94% |
| 2000 Q3 | 35.24 Million USD | 5.96% |
| 1999 Q4 | 32 Million USD | 16.36% |
| 1999 Q1 | 24.7 Million USD | 1.65% |
| 1999 Q3 | 27.5 Million USD | 5.77% |
| 1999 Q2 | 26 Million USD | 5.26% |
| 1999 FY | 32 Million USD | 31.69% |
| 1998 Q3 | 23.2 Million USD | 3.11% |
| 1998 FY | 24.3 Million USD | 0.0% |
| 1998 Q2 | 22.5 Million USD | 0.0% |
| 1998 Q4 | 24.3 Million USD | 4.74% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -492.148% |
| BrainsWay Ltd. | 62.97 Million USD | -194.945% |
| Cerus Corporation | 197.74 Million USD | 6.076% |
| Envoy Medical, Inc. | 7.64 Million USD | -2331.06% |
| electroCore, Inc. | 16.38 Million USD | -1033.417% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2314.626% |
| IceCure Medical Ltd | 16.41 Million USD | -1031.828% |
| Inogen, Inc. | 326.19 Million USD | 43.061% |
| OrthoPediatrics Corp. | 449.58 Million USD | 58.688% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -581.089% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1020.29% |
| MaxCyte, Inc. | 268.27 Million USD | 30.767% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2193.761% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5013.912% |
| Orthofix Medical Inc. | 925.31 Million USD | 79.928% |
| PAVmed Inc | 33.11 Million USD | -460.805% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -29.474% |
| RxSight, Inc. | 182.55 Million USD | -1.744% |
| Sight Sciences, Inc. | 166.65 Million USD | -11.45% |
| SI-BONE, Inc. | 230.42 Million USD | 19.395% |
| TELA Bio, Inc. | 78.04 Million USD | -137.973% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 26.269% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1630.969% |
| Acutus Medical, Inc. | 53.96 Million USD | -244.205% |
| Talis Biomedical Corporation | 98.34 Million USD | -88.868% |
| Spectral AI, Inc. | 10.69 Million USD | -1637.121% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 15.054% |
| CVRx, Inc. | 115.22 Million USD | -61.186% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -216.621% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -5862.052% |
| Bioventus Inc. | 810.91 Million USD | 77.096% |
| Venus Concept Inc. | 93.65 Million USD | -98.318% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -621.994% |
| LivaNova PLC | 2.42 Billion USD | 92.355% |
| 908 Devices Inc. | 202.98 Million USD | 8.497% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 76.934% |
| Nemaura Medical Inc. | 14.56 Million USD | -1175.356% |
| NeuroPace, Inc. | 107.65 Million USD | -72.533% |
| LENSAR, Inc. | 69.58 Million USD | -166.915% |
| Apyx Medical Corporation | 79.24 Million USD | -134.393% |
| Cutera, Inc. | 346.29 Million USD | 46.365% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -342.053% |
| BioSig Technologies, Inc. | 1.79 Million USD | -10229.978% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 31.371% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -335.37% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 95.089% |
| Axonics, Inc. | 719.92 Million USD | 74.201% |
| Outset Medical, Inc. | 313.8 Million USD | 40.812% |
| IRIDEX Corporation | 34.43 Million USD | -439.357% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 54.108% |
| IRadimed Corporation | 92.15 Million USD | -101.542% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -3435.078% |
| INVO Bioscience, Inc. | 20.88 Million USD | -789.194% |
| Telesis Bio, Inc. | 70.41 Million USD | -163.784% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -20.526% |
| Varex Imaging Corporation | 1.24 Billion USD | 85.137% |
| Quipt Home Medical Corp. | 247.4 Million USD | 24.928% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1894.984% |
| Pulmonx Corporation | 178.95 Million USD | -3.79% |
| Dynatronics Corporation | 25.94 Million USD | -615.995% |
| Modular Medical, Inc. | 13.8 Million USD | -1245.209% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1631.453% |
| Semler Scientific, Inc. | 78.06 Million USD | -137.921% |
| InMode Ltd. | 863.28 Million USD | 78.485% |
| Bruker Corporation | 4.24 Billion USD | 95.63% |
| Cytosorbents Corporation | 53.26 Million USD | -248.725% |
| DexCom, Inc. | 6.26 Billion USD | 97.035% |
| Align Technology, Inc. | 6.08 Billion USD | 96.947% |
| Viveve Medical, Inc. | 25.91 Million USD | -616.756% |
| ZimVie Inc. | 1.2 Billion USD | 84.591% |
| Movano Inc. | 9.42 Million USD | -1871.479% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 62.679% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5013.912% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -216.621% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 80.504% |
| Profound Medical Corp. | 43.68 Million USD | -325.151% |
| Insulet Corporation | 2.58 Billion USD | 92.824% |
| enVVeno Medical Corporation | 48.63 Million USD | -281.892% |
| iCAD, Inc. | 41.41 Million USD | -348.435% |
| Nuwellis, Inc. | 9.77 Million USD | -1801.054% |
| Biotricity, Inc. | 5.94 Million USD | -3025.437% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 57.12% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2152.406% |
| InspireMD, Inc. | 47.64 Million USD | -289.843% |
| PAVmed Inc. | 33.11 Million USD | -460.805% |
| BIOLASE, Inc. | 35.1 Million USD | -429.139% |
| Beyond Air, Inc. | 56.96 Million USD | -226.07% |
| FONAR Corporation | 214.24 Million USD | 13.309% |
| AxoGen, Inc. | 196.82 Million USD | 5.636% |
| Vivani Medical, Inc. | 45.79 Million USD | -305.557% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 34.006% |
| Inari Medical, Inc. | 674.23 Million USD | 72.453% |
| UFP Technologies, Inc. | 404.13 Million USD | 54.042% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -693.78% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1854.444% |
| Tenon Medical, Inc. | 6.34 Million USD | -2827.234% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -1874.413% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -79.196% |
| AdaptHealth Corp. | 4.61 Billion USD | 95.98% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1108.806% |
| NanoVibronix, Inc. | 6.67 Million USD | -2682.934% |
| Quanterix Corporation | 425.01 Million USD | 56.299% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -1894.984% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -245.698% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 89.362% |
| TransMedics Group, Inc. | 706.04 Million USD | 73.694% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -193.919% |
| NeuroMetrix, Inc. | 21.42 Million USD | -766.921% |
| Hyperfine, Inc. | 94.19 Million USD | -97.171% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 30.862% |
| Biomerica, Inc. | 9.25 Million USD | -1907.056% |
| Bone Biologics Corporation | 3.73 Million USD | -4869.095% |
| AVITA Medical, Inc. | 144.33 Million USD | -28.677% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -3714.97% |
| Silk Road Medical, Inc | 265.3 Million USD | 29.994% |